Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03217188 · ClinicalTrials.gov registry record · Phase 2
Proton Re-Irradiation for Recurrent Head and Neck Cancer
A Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 87
- Enrollment target
NCT03217188: Completed Phase 2 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03217188 is a Phase 2 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03217188, a Phase 2 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the tumor control and the side effects of using proton therapy for head and neck cancer that has come back.
Interventions
- RADIATION conventionally fractionated full dose re-irradiation
- RADIATION hypofractionated palliative re-irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2026-03-18 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03217188
The ClinicalTrials.gov registry entry for NCT03217188 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which conventionally fractionated full dose re-irradiation is the first listed.
NCT03217188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03217188 about?
NCT03217188 is a clinical study titled "Proton Re-Irradiation for Recurrent Head and Neck Cancer". The purpose of this study is to evaluate the tumor control and the side effects of using proton therapy for head and neck cancer that has come back.
What is the current status of trial NCT03217188?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 87 participants. The study started on 2017-07-10. Estimated completion is 2026-03-18.
What interventions are being tested in trial NCT03217188?
The interventions under investigation include: conventionally fractionated full dose re-irradiation (RADIATION), hypofractionated palliative re-irradiation (RADIATION).
Who is sponsoring clinical trial NCT03217188?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.